The Ukrainian government has approved a list of health conditions that will qualify patients for medical marijuana under the country’s cannabis law that was enacted by President Volodymyr Zelensky last month.
On Friday, Ukraine’s Ministry of Health revealed a list of about 20 qualifying conditions for which medical cannabis can be prescribed to patients, while noting that additional conditions could be added down the line if it’s deemed medically appropriate.
Those conditions include multiple sclerosis, neuropathy, shingles, cerebral palsy, spinal cord injuries, complications from chemotherapy, Parkinson’s disease, childhood epilepsy and weight loss associated with eating disorders. The ministry also noted that a medical advisory committee could approve additional conditions in the future.
Read full report
Official Govt Statement
The Ministry of Health has approved the list of diseases and conditions for which medical cannabis will be prescribed
09/27/2024 3644
The Ministry of Health has determined the specifics of the prescription and use of medical cannabis medicines produced in a pharmacy. The list of diseases and conditions for which they will be prescribed is also approved. The list is based on the most up-to-date research and evidence of effectiveness, and it will be periodically revised as new research evidence becomes available.
Medicines based on medical cannabis can only be obtained with an electronic prescription from a primary care physician or a physician providing specialized medical care. Data on such appointment will be entered into the electronic health care system (EHS).
It will be possible to prescribe medicinal cannabis if the patient has one of the following diagnoses (in brackets are the codes according to the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision):
Chronic or neuropathic pain (R52.2) and/or spasticity (R25.2) due to the following diseases:
malignant neoplasms (C00 – C97);
diabetic neuropathy (E10.4, E11.4, E12.4, E13.4, E14.4);
multiple sclerosis (G35);
damage to the trigeminal (G50) and facial nerve (G51);
neuralgia due to shingles (G53.0);
damage to nerve roots and plexuses (G54);
compression of nerve roots and plexuses in diseases (G55);
mononeuropathy of the upper limb (G56);
mononeuropathy of the lower limb (G57);
polyneuropathies and other lesions of the peripheral nervous system (G60-G64);
cerebral palsy and other paralytic syndromes (G80 – G83);
spinal cord injuries (S14.0, S14.1, S14.7, S24.0, S24.1, S24.7, S34.0, S34.1, S34.3, S34.7, T09.3, T91. 3);
intracranial injuries (S06).
Nausea and vomiting (R11) due to chemotherapy (Z51.1) during treatment of neoplasms (C00 – C97).
Parkinson’s disease (G20), de la Tourette’s syndrome (F95.2).
Refractory (drug-resistant) epilepsy (G40 – G41).
Diseases causing seizures in childhood: Lennox-Gastaut syndrome (G40.4), Dravet syndrome (G40.4), tuberous sclerosis (Q85.1).
Weight loss associated with anorexia (R63.0) in patients with human immunodeficiency virus disease (B20-B24).
Other diseases (A00 – T98) – only if there is an opinion of the medical and advisory commission.
Source: https://moz.gov.ua/uk/moz-zatverdilo-perelik-hvorob-i-staniv-za-yakih-priznachatimetsya-medichnij-kanabis
